Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

54 results about "Zinc cation" patented technology

ZINC cation is an enzyme that catalyzes the HYDROLYSIS of terminal, non-reducing alpha-D-mannose residues in alpha-D-mannosides.

Baby Care Skin Protectant Compositions for Diaper Rash

The present invention provides a comprehensive solution to skin problems of infants and incontinent adults related to diaper rash, also known as diaper dermatitis. This is based on certain novel divalent metal and quaternary ammonium complexes (ion-pairs) of zeolites (that are made by an in-situ process), which in synergistic combination with certain other compositions, provide a comprehensive treatment for diaper rash that encompasses the following aspects: (1) deactivation of lipase and protease enzymes on skin surface, (2) the controlled-release delivery of skin protectant compositions, such as divalent metal zinc cation, (3) trapping of acidic and alkaline chemicals deposited on skin from body exudates and enzyme activity, (4) controlled-release delivery of anti-inflammatory agents, and COX and LOX enzyme inhibitors, (5) controlled-release delivery of antibacterial and antifungal compositions, and (6) absorption of excess moisture in the diaper zone.
Owner:BIODERM RES

Colonic delivery using Zn/pectin beads with a Eudragit coating

Drug delivery systems that can deliver therapeutic and/or diagnostic agents to the colon are disclosed. The systems include pectin beads crosslinked with zinc or any divalent cation of interest, which beads are then coated with Eudragit®-type polymers. The drug delivery systems are orally administrable, but can deliver the active agents to the colon. In some embodiments, they can administer the agents to various positions in the gastro-intestinal tract, including the colon. The agent can be a small molecule, peptide, protein, nucleic acid, or complex structures of natural, recombinant or synthetic origin. In still other embodiments, the agent is a diagnostic agent. The agents can be used to diagnose, treat or investigate humans and animals for a variety of conditions, including infectious diseases, inflammatory diseases, cancers and the like. Colon-specific delivery is obtained by formulating a prophylactic, therapeutic, and/or diagnostic agent with specific polymers that degrade in the colon, such as pectin. The pectin is gelled/crosslinked with a cation such as a zinc cation. The formulation, typically in the form of ionically crosslinked pectin beads, is subsequently coated with a specific polymer such as a Eudragit® polymer. Processes for obtaining such beads are also disclosed.
Owner:DA VOLTERRA FACULTE DE MEDECINE BICHAT

Polyamide Composition Containing Ionomer

InactiveUS20130171394A1Poor salt stress crack resistanceExcellent salt stress crack resistanceLayered productsPretreated surfacesIonomerCrack resistance
Disclosed is a composition comprising polyamide comprising nylon-6 and optionally nylon-6,66, nylon-66, nylon-610, nylon-612, nylon-11, nylon-12 and an ionomer comprising an ethylene carboxylic acid copolymer, wherein 30 to 90% of the total carboxylic acid functionalities are neutralized to salts with a mixture of zinc cations and cations of a second metal selected from Group 1 of the Periodic Table of the Elements wherein the salts comprise from 20 to 90% equivalents of zinc. Articles prepared from the composition have improved salt stress crack resistance when exposed to zinc chloride solutions.
Owner:EI DU PONT DE NEMOURS & CO

Colonic delivery of metallo-dependent enzymes

Drug delivery systems for delivering agents capable of reducing the quantity of residual antibiotics reaching the colon following oral or parenteral antibiotic therapy, and for delivering metallo-dependent enzymes, and methods of using the drug delivery systems, are disclosed. The drug delivery systems include pectin beads that encapsulate the active agent (which can be a metallo-dependent enzyme), where the pectin is crosslinked with zinc or any divalent cation of interest and the pectin beads are coated with Eudragit®-type polymers. The drug delivery systems are orally administrable, but can deliver the active agents to the colon. In some embodiments, they can administer the agents to various positions in the gastro-intestinal tract, including the colon. One metallo-dependent enzyme is the β-lactamase L1 from Stenotrophomonas maltophilia, and agents that inactivate macrolide, quinolone, fluoroquinolone or glycopeptide antibiotics can also be used. The delivery of the active agent can be modulated to occur at various pre-selected sites of delivery within the intestinal tract by gelling / crosslinking a mixture of the active agent, such as a metallo-dependent enzyme, and pectin, with divalent metallic cations such as Ca+2 or Zn+2. A stable metallo-dependent enzyme formulation can be delivered to the lower intestine or colon. The use of zinc cations to crosslink the pectin is particularly preferred when specific metallo-dependent enzymes, which are Zn2+ dependent, could interact with other cationic species if they were used to gel the pectin beads and thus adversely affect the activity of such metallo-dependent enzymes.
Owner:ASSISTANCE PUBLIQUE HOPITAUX DE PARIS +2

Nonsludging zinc phosphating composition and process

Electrolysis using a suitable electrolyte provides a completely nonsludging zinc phosphate conversion coating process that produces a high quality conversion coating in a very short time. The suitable electrolyte contains at least water, dissolved nitric acid, and dissolved zinc cations and optionally also contains m chemically distinct species of cations other than zinc and n chemically distinct species of anions other than anions derivable by ionization of phosphoric and nitric acids, each of m and n independently being zero or a positive integer. Preferably, the liquid composition contains as additive at least one selection from nitrous acid, permanganic acid, peroxysulfuric acid, hydrogen peroxide, chloric acid, perchloric acid, nitrobenzenesulfonic acid, hydroxylamine, starch / phosphoric acid esters, fluorine compounds, and salts of the preceding; and / or the metal substrate is subjected to cathodic electrolysis after the workpiece has been brought into contact with a weakly basic aqueous colloidal solution that contains titanium oxide, titanium hydroxide, and zinc phosphate.
Owner:HENKEL KGAA

Acidic zincating solution

An aqueous, acidic zincating composition comprising: zinc cations; fluoride anions; and a carboxylic acid having at least one additional —OH substituent is provided that is useful in a process of making a corrosion resistant article comprising contacting an article having an aluminum surface with the zincating composition and thereafter coating the article with an autodeposition coating.
Owner:HENKEL KGAA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products